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Cryptococcus at Work: Gene Expression during Human Infection
Rajendra Upadhya,a Maureen J. Donlin,b,c Jennifer K. Lodgea
Department of Molecular Microbiology, Washington University School of Medicine,a and Edward A. Doisy Department of Biochemistry and Molecular Biologyb and
Department of Molecular Microbiology and Immunology,c Saint Louis University School of Medicine, St. Louis, Missouri, USA
ABSTRACT Meningitis is a frequent manifestation of infection due to Cryptococcus neoformans and a major cause of increased
morbidity in patients with AIDS. Numerous in vitro gene expression and genetic studies of the fungus have predicted a myriad
of genes, pathways, and biological processes that may be critical for pathogenesis, andmany studies using animal models have
supported the role of these processes during infection. However, the relevance of these hypotheses based on in vitro and animal
models has often been questioned. A recent study by Chen et al. [Y. Chen, D. L. Toffaletti, J. L. Tenor, A. P. Litvintseva, C. Fang,
T. G. Mitchell, T. R. McDonald, K. Nielsen, D. R. Boulware, T. Bicanic, and J. R. Perfect, mBio 5(1):e01087-13, 2014] represents
an important step in understanding the cryptococcal response during human infection.
Cryptococcus neoformans is distributedworldwide, grows in soil,fends off a variety of phagocytic predators, and can infect a
wide variety of animals and plants. The presence and survival of
the fungus in these diverse environmental and host conditions
imply that the fungus has evolved awell-orchestrated gene expres-
sion program that enables it to adapt andproliferate under various
conditions. The data from testing a multitude of genetic variants
under defined in vitro growth conditions and in multiple animal
infection models for C. neoformans have been used to formulate
and test hypotheses about pathogenesis in humans.
Examination of gene expression profiles of C. neoformans un-
der specific in vitro stress conditions that are thought to mimic
conditions encountered by the fungus within the human host has
been widely used to explore the molecular response of C. neofor-
mans to predicted host stress conditions. Amajor advantage of the
in vitro studies is that many variables can be carefully controlled
and sufficient biological and technical replicates can be generated
to obtain highly reproducible and significant data. These in vitro-
derived data sets have suggested roles for different biological pro-
cesses during pathogenesis. However, data from one narrowly de-
fined set of experiments may not be generalizable to animal or
human infection. Even within one animal host, the fungus has to
survive under diverse tissue and immunologic stress conditions.
Our understanding of how the fungus adapts to these changing
conditions within the host is limited, and in vitro experiments are
unlikely to fully explain these adaptative responses. However, ob-
taining sufficient statistical power in studies that are limited by
having few biological samples makes it more difficult to generate
firm conclusions.
Therefore, one way to ascertain the involvement of mecha-
nisms of pathogenesis gleaned from experiments carried out un-
der laboratory conditions is to directly examine the genomic re-
sponse of the fungus growing inside an infected human patient. A
major technical hurdle to examining gene expression during hu-
man infection has been obtaining sufficient high-quality material
to generate the RNA for analysis, due to the limited number of
fungal cells and the presence of large amounts of polysaccharide
capsule, which interferes with the purity of RNA. More impor-
tantly, these experiments are particularly challenging to interpret
due to the difficulty of controlling for multiple variables, includ-
ing stage of infection, host responses, complications of other in-
fections, and the strain of Cryptococcus that is causing the infec-
tion. The variability introduced by different infecting genotypes
was well demonstrated in a study by Wiesner et al. (1) in which
they analyzed 140 Cryptococcus strains isolated from 111 human
AIDS patients presenting with Cryptococcus meningitis. The
found a significant correlation between the genotype and the phe-
notypic response elicited by the fungal strain in the human host.
Chen and colleagues in John Perfect’s laboratory at Duke Uni-
versity (2) have pioneered the examination of C. neoformans gene
expression during human infections. They have succeeded in ex-
tracting sufficient amounts of good-quality RNA from C. neofor-
mans growing in the cerebrospinal fluid (CSF) of two AIDS pa-
tients. They subjected the RNA samples to whole-genome
transcriptome analysis employing transcriptome sequencing
(RNA-Seq). In addition, they purified RNA from the same yeast
strains after culturing them in yeast extract-peptone-dextrose
(YPD) and in humanCSF under laboratory conditions. Theywere
able to produce high-quality sequence data from the RNA isolated
from the yeast cells collected fromhumanpatients, with 95 to 98%
of the reads mapping to the predicted genes of the H99 genome.
One of the surprising revelations of this study is the high similarity
of the gene expression profiles between the samples from cells
growing in theCSF of the humanpatient and cells growing in YPD
under laboratory conditions. This is intriguing because there are
substantial differences in the growth conditions, including CO2
levels, stress, exposure to light, and nutrient composition. The
ontology analysis of the differentially expressed genes in the pa-
tient’s CSF and in YPD in comparison to cells grown in CSF in
vitro indicated that the expression of genes in the cellular metab-
olism category increased, suggesting that yeast cells are actively
growing in CSF inside the human patient. Active metabolism was
also observed inC. neoformans in theCSFof infected rabbits by the
use of serial analysis of gene expression (SAGE) (3), along with
induction of various other biological processes.
The environment in the lung may be very different from the
environment in the CSF. Comparative SAGE analysis of yeast cells
isolated from infectedmouse lungs and those from infected rabbit
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CSF showed that the gene expression profiles of C. neoformans
growing in mouse lung was significantly different from that of the
yeast isolated from rabbit CSF. The cells from rabbit CSF most
closely resembled cells grown in vitro in low-iron medium (LIM)
(4).Moreover, when a library of ~1,400 gene deletion strains were
subjected to a virulence study employing a mouse inhalation
model, there were 164 mutants which showed decreased ability to
infect and grow inside the mouse lung (5). On the other hand,
when the same deletion strain library was used for survival studies
of the mutant strains in human CSF, there were only 13 mutants
that showed impaired growth in human CSF (6). These data fur-
ther support the requirement of more robust mechanisms of gene
regulatory networks when the fungus is grown in the lung than
when the fungus is grown in humanCSF. One possibility is that in
human CSF, C. neoformans may experience mild stress, which in
turn may positively affect fungal growth. When C. neoformans
cells are grown under in vitro conditions, we have observed that
mild stress, such as low oxidative stress conditions, increases the
rate of growth significantly (reference 7 and unpublished data).
Chen et al. (2) did find 20 genes that were upregulated only in
the cells growing in the human CSF, and these included genes
predicted to be critical for fungal virulence. One of the genes up-
regulated inside the human body was a homolog of SRX1, a gene
involved in oxidative stress resistance, and SRX1 was recently
shown to be critical forC. neoformans pathogenesis (8). Two other
genes, ENA1 and RIM101, were upregulated under CSF condi-
tions and have been shown to be important for cryptococcal vir-
ulence in animal models (9, 10).
To associate the fungal gene expression profile with a specific
genotype, Chen et al. identified the genotype of the two strains
isolated from human CSF. They found that one isolate belonged
to the G0 subtype and the other to the HC1 subtype of C. neofor-
mans var. grubii, an observation consistent with fact that the two
strains were obtained from individuals residing in different geo-
graphical locations. Comparison of the gene expression patterns
of these two strains indicated that around 100 genes are differen-
tially expressed between theG0 andHC1 subtypes. Further single-
nucleotide polymorphism (SNP) analysis revealed the presence of
a single-nucleotide variant (SNV) in these isolates, and the conse-
quence of this SNV was demonstrated by the increased sensitivity
of the HC1 strain, compared to the G0 strain, to exogenous per-
oxide, providingmolecular evidence for the potential influence of
SNPs on fungal virulence and subsequent clinical outcome.
Understanding the role and expression of various cryptococcal
biological processes during the different stages of human infection
is important to help develop effective therapeutic interventions
for fungal infections. Depending on their environment of growth,
C. neoformans isolates may exhibit varied sensitivity to growth
inhibitory molecules. The results presented by Chen and col-
leagues are important first forays into the exploration of genomic
regulation in the human host.
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